Transcatheter Technologies completes durability testing on its Trinity 3rd-generation transcatheter aortic valve implantation system, after putting the device through an estimated 15 years' worth of cycles.
German device maker Transcatheter Technologies GmbH said it finished durability-testing Trinity transcatheter aortic valve implantation system.
The company expects Trinity to be "the world's 1st 'truly repositionable'" replacement aortic valve. The device was put through 600 million cycles, or around 15 years, of durability testing by an independent lab, which reported that the device far exceeded minimum standards, according to a press release.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1b8psMS
Cap comentari:
Publica un comentari a l'entrada